rs141477666
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_153240.5(NPHP3):c.1189C>T(p.Arg397Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00513 in 1,613,692 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R397H) has been classified as Likely benign.
Frequency
Consequence
NM_153240.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPHP3 | NM_153240.5 | c.1189C>T | p.Arg397Cys | missense_variant | 7/27 | ENST00000337331.10 | |
NPHP3-ACAD11 | NR_037804.1 | n.1293C>T | non_coding_transcript_exon_variant | 7/45 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPHP3 | ENST00000337331.10 | c.1189C>T | p.Arg397Cys | missense_variant | 7/27 | 1 | NM_153240.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00322 AC: 490AN: 152202Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00304 AC: 764AN: 251380Hom.: 4 AF XY: 0.00291 AC XY: 396AN XY: 135876
GnomAD4 exome AF: 0.00533 AC: 7785AN: 1461372Hom.: 31 Cov.: 31 AF XY: 0.00513 AC XY: 3730AN XY: 727038
GnomAD4 genome ? AF: 0.00322 AC: 490AN: 152320Hom.: 2 Cov.: 32 AF XY: 0.00303 AC XY: 226AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 02, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 11, 2022 | Variant summary: NPHP3 c.1189C>T (p.Arg397Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.003 in 251380 control chromosomes, including 4 homozygotes. The variant was predominantly found within the Non-Finnish European subpopulation at a frequency of 0.005. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 12-fold higher than the estimated maximal expected allele frequency for a pathogenic variant in NPHP3 causing Joubert Syndrome and Related Disorders phenotype (0.0004), strongly suggesting that the variant is a benign polymorphism. c.1189C>T has been reported in the literature in the heterozygous state in individuals affected with retinal- or renal dysorders (e.g. Tiwari_2016, Arno_2017, Hoefele_2007), however in these cases other (potentially) pathogenic variants were also described, including a homozygous deletion variant in NPHP1 that was found in two siblings affected with nephronophthisis (Hoefele_2007). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters have assessed this variant since 2014: one submitter classified the variant as of uncertain significance, two as likely benign, and one as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Renal-hepatic-pancreatic dysplasia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
NPHP3-related Meckel-like syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Nephronophthisis 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Nephronophthisis Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2020 | This variant is associated with the following publications: (PMID: 27392076, 17855640, 23188109) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at